Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Receptor tyrosine-protein kinase erbB4 (HER4) is a member of the ErbB family of receptor tyrosine kinases. It plays critical roles in the development and maintenance of the cardiovascular system, central nervous system, and mammary gland. Ligand binding, such as Neuregulins, promotes dimerization and activation of downstream signaling pathways like MAPK/ERK. Mutations in ERBB4 have been identified in various cancers and neurodegenerative diseases. Multiple isoforms exist due to alternative splicing, leading to functional diversity.
Tyrosine kinase inhibition upon ligand binding and dimerization, leading to downstream signaling pathway modulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Receptor tyrosine-protein kinase erbB4 (HER4).